. and cornpad to 2 normal controls. The rse 01 the patients ranged between 3-3/4 and 35 yeus. Testiculu tissue w u obtained during surgery lor male genitopluty in 4 cues. and durlng cutntion In one individual, who hod been reatd unequivocally u a lemale. Whlle the tslticular tissue 01 the 2 prepubertal MPH metabolized progesterone lo andrortenedione only, ud that in a limited extent. Ute 3 portpubertal MPH metabolized progesterone to 1 6~-m d 168-hydroxyprogemterone ( 16-OHP). 17-hydroxyprogesterone. androsUnedione and to testosterone. These MPH meubolized androstenedione lo testosterone or well. to a compuable extent u the controls. The Michaells constant of these ructions w u E~m i~u lor the MPH and the controls. An 7.8 to 12.8-lold increase in the production 01 16-OHP. and a 4.6 to 11.5-fold Inhibition 01 the 17-hydroxylue was lound In the testem 01 the MPH. The preference of androatenedione production by the testes of 2 MPH w u examined wing a equimoiar concentration 01 II4CI-progesterone and IH31-prqnenolone u substrates. Whlle the llow 01 substrates in the normal testes was equal or slightly prelerable through the A-4 pathway. a more than 8-tima preference 01 the A-5 pathway was noted in the testes of the MPH. A luge ~ccumulation or DHEA was found upon omission of NAD, the 30-steroid dehydrogenase-lsomsrue colutor. supporting the contention that In MPH androstmedlone is mainly produced through the A-5 pathway. Further support lor thi8 w u the lindlng that the 3H114C ratio of androstenedione and testosterone produced lrom both substrates w a 8-times higher in MPH than in controls. MPH due to 17-ketoreductue deliclency appears to be a mlxture 01 complex melabollc aberrations in the androgen biosynthetlc pathway.
1
During an uneventful pregnancy, prenatal sex determination of the fetus was performed on parental request. A 46.XY karyotype was found. At term, a phenotypic girl was born, and a second chromosome analysis confirmed the 46,XY constitution. There was a complete vagina, but on echography, gonads and uterus could not be seen with certainty. At age 8 months. FSH was 53 1.1U1mol. LH 3uUI1, testgsterone 1.1. and androstenedione 1.2 nmolll. After hCG (5000 IU/m ) , there was no increment of testosterone. Urinary steroids before and after hCG and ACTH (gas chromatography on capillary column) suggest the presence of 17.20-desmolase deficiency: basal cortisol (total of THE, THF, alloTHF, cortolone, B-cortolone 1.95 vmolld) and progesterone metabolites (pregnanediol 0.14, pregnanetriol 0.2 ~molld) were normal, but individual 17-ketosteroids (androsterone 0.42, etiocholanolone 0.14) low or undectable (DHEA). Thus, inspite of the c o m n cytochrome P450, 17d-hydroxylating activity was normal. Urinary 5RI50Lratio was normal (0.33). In fibroblasts cultured from biopsy at labium majora androgen receptor binding was just below normal. but surprjsin~ly the Ed-reductase activity reduced (0.60 pmollmg protein-'h-; normal >l). This reduction appears to be secondary to the lack Of the substrate testosterone during embryogenesis. 
I
ARGUMENTS FOR A NON-Y TESTICULAR DETERMINING GENE. 9 patients having testicular tissue with 46,XX karyotype, aged 1 month to 16 years and followed through puberty, were studied. According to their phenotype they were 2 46,XX males with normal male phenotype and 7 with abnormal external genitalia (AG), among whom 4 with hypospadias and 3 with true hermaphroditism (TH). The endocrine data were identical in the three groups: testosterone normal during puberty, then decreased in adulthood, gonadotropin levels being already above the control values at mid-puberty. Biopsies were identical in the 2 subgroups of AC patients up to 5 years: no difference with controls, regardless of the ovarian part of the ovotestis ; after 8 years, germ cells disappeared and dysgenesis became obvious. In one patient, the ovarian zone of 1 the gonad appeared only after complete serial cuts of the gonad removed. Southern analysis of Y-DNA sequences displayed the presence of Y-specific mnterial in 46,XX classical males and the lack of the sequence in all patients with AG. These findings, together with the knowlegde of familial cases of XX males with AG and TH allow to consider that XX males with AC and TH are the alternative expression of the same genetic defect and that a non-Y testis determining factor might be active in these patients in place of the testis determinants usually present on the Y chromosome, or on the X chromosome in XX classical males.
Basal and androgen-stirmlated aromatase activity was studied in genital skin fibroblasts (GSF) from normals (n = 18) and patients with androgen insensitivity syndrome (AIS; n = 8).
Enzyme activity was determined fgom the release of C3tl1 1120 following the conversion of ClB-HI androstenedione (ClB-3HI-A) to oestrone. Using a substrate concentration 2-50 nM, saturatior kinetic analysis yielded a Vmax (maxirmm velocity) of 184 f 104. fmollmg proteinlhr (mean + SO) and a kM (Michaelis-Menten constant) of 6.9 2nM in normal GSF strains, and values of 186 2 9.1 (Vmax) and 8.5 + 2.6 (kM), respectively in AIS strains.
Androgens increased aromatase activity in normal GSF strains. Pre-incubation with 1 0 M mibolerone (a synthetic androgen) for 48 hr produced a 4.2 -38 fold increase in basal aromatase activity. The response in receptor-positive (n = 5) and receptor-deficient (n = 2) partial AIS strains was 12.4 -23.5 and 1.1 -2.4 fold, respectively. There was no stimulaton of aromatase in a receptor-negative complete AIS strain. The results provide evidence of a permissive role for androgens in the control of peripheral aromatase activity. The effect is androgen receptor mediated based on studies of GSF strains from AIS patients with a dysfunctional receptor, and may provide an E i t i o n a l in vitro qualitative marker of androgen pons1 veness. patients with impaired testlcular functlon (gonadal dysgenesls. 178-hydroxysterold-dehydrogenase defect). 4 patlents with target organ lnsensltlvlty (partlal and complete androgen reslstance). and in 20 controls. In testicular dysfunction and In the controls SHBG-levels decreased slgnlflcantiy (~(0.001) down to a mlnlmum of 61.6 % i 6.0 (SD) (Stanozolol) and 66.2 f 10.3 (SD) (Oxandrolone) of the lnitlal values at days 6.6.7. or 8 after initiation of the test. whlle-in partlal androgen resistance the decrease was moderate (81% and 89%). and absent In complete testlcular feminlzatlon. Differences In all other parameters were not statlstlcally signlflcant. Conclusion: 1.) The SHBG-decrease induced by short term anabollc steroid application Is a speclflc reactlon. 2.) Thls reactlon requlres regular target tlssue sensltlvity. 3.) It can be used for the differentiation of testicular dysfunctlon syndromes from androgen lnsensltlvity syndromes. 1 patient with female phenotype at birth, a history of bilateral inguinal hernia and karyotype46,XY was considered to have MPH due to testicular feminization syndrome until 13years of age when she developed cl itoromegaly (3.5 x 1.8 cm), a deep-pitched voice and breast development. The blind vaainal ouch ended at 3 cm and no I prostatic tissue was palpable at-recta'l examination Peri heral serum steroid analyses revealed markedly elevated levels 01 androstenedione (A4) (4.20 nglml ) and OHEA (9.50 nglml ) and moderately raised concentrations of testosterone (T)(1.72 nglml). The finding of an elevated A411 ratio was consistent with 17-ketoreductase deficiency. Spermatic vein blood with an even higher A4lT ratio (22:l: suggested testicular origin of the increased secretion of A4. Neither HCG nor ACTH administration caused further significant increases of A4 or T, whereas OHEA showed a 3-fold rise after ACTH. The gaschromatographic rofl le of urlnary sterold metabolites 1nd1-cated predom~nance of &-reduced ~terolds. Surgical exploration for gonadectomy revealed an lngulnal rlght and an abdominal left testicle. No remnants of the Mullerian ducts could be found. Histologically, both gonads showed epididymes and vasa deferentia as well as atrophic testicular tissue with Leydigcell hyperplasia, Sertoli cells and few s ermatogonia. Genital skin fibroblasts exhibited normal androgen ginding and 50-reductase activity. After gonadectomy A 4 and T levels fell to normal;, OHEA,however, remained strikin ly high (17 nglml) suggesting a coexlstlng partial adrenal 30-HSD deficiency.
